AbCellera Biologics Inc. (ABCL): A Bull Case Theory
We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.
Abcellera Biologics Inc. (ABCL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 27,525,640 | $80,650,125 | 0.86% | |
| 2. | Prosight Capital Lawrence Hawkins | 7,350,000 | $21,535,500 | -20% | 5.95% |
| 3. | OrbiMed Advisors Samuel Isaly | 4,180,768 | $12,249,650 | 0.25% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 2,608,400 | $7,642,612 | +20% | 0.01% |
| 5. | Tang Capital Management Kevin C. Tang | 2,582,816 | $7,567,651 | +13% | 0.5% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.61 | 283,516 | Large Shareholder | 56,086,009 | 2024-08-29 | Filing | |
| $4.46 | 10,000 | Director | 86,000 | 2023-11-08 | Filing | |
| $4.64 | 20,000 | Director | 76,000 | 2023-11-06 | Filing | |
| $4.91 | 20,000 | Director | 1,323,397 | 2023-09-22 | Filing | |
| $5.19 | 20,000 | Officer, Director | 2,040,122 | 2023-09-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.93 | 137,351 | Director | 128,862 | 2021-09-01 | Filing | |
| $16.95 | 162,649 | Director | 266,213 | 2021-08-31 | Filing | |
| $25.50 | 100,000 | Director | 1,003,397 | 2021-06-22 | Filing | |
| $24.03 | 5,598,420 | Large Shareholder | 55,604,330 | 2021-06-09 | Filing | |
| $25.50 | 401,580 | Large Shareholder, Officer, Director | 233,500 | 2021-06-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,236,465 | $35,852,843 | 0.02% | |
| 2. | 10,624,185 | $31,128,862 | 0.03% | |
| 3. | 7,933,613 | $23,245,486 | 0% | |
| 4. | 4,500,000 | $13,185,000 | 0% | |
| 5. | 4,105,095 | $12,027,928 | 0.16% |
News See All
12 Best Canadian Penny Stocks to Buy According to Analysts
According to a report by the Government of Canada, released on December 16, the country's economic outlook has been revised upward, as private-sector economists forecast moderate growth of around 2% in...
AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to AbCellera’s Q3 2024 Business Update Conference Call. My name is Tamiya, and I will facilitate the audio portion of today's interactive broadcast.
8 Penny Stocks with Biggest Upside Potential According to Analysts
The Federal Reserve slashed interest rates by a half point in September, kickstarting its first easing campaign in four years.
10 Best Multibagger Penny Stocks of 2025
The term "multibagger" was coined by Peter Lynch in his book titled "One Up On Wall Street" to describe those stocks whose share prices increase several times more than an investor's original investment...
10 Best Canadian Penny Stocks to Buy Now
As we navigate the complexities of 2024, Canada's economic landscape presents a unique blend of challenges and opportunities.
AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to AbCellera’s Q2 2024 Business Update Conference Call. My name is Tamiya, and I will facilitate the audio portion of today’s interactive broadcast.
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to AbCellera's Q1, 2024 Business Update Conference Call. My name is Harry and I will facilitate the audio portion of today's interactive broadcast.
Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks
In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read our article Billionaire...
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript
AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc.
Billionaire Hedge Funds
